Category Archives: News

  • -
Heart Health Month

ABS Executives Support Heart Health Month

Category : News

Drawing Attention To A Global Crisis

Almost 18 million people will die in 2018 because of cardiovascular disease and related conditions. This is humanity’s greatest killer and it increasingly is becoming the number one killer of both genders in most places.

February is Heart Health Month. ABS’s CEO Charles Laverty and co-founder and chief medical officer Dr. Mehran Khorsandi want to encourage people to support our efforts to address this global issue.

A Global Problem Affecting All Groups

Advanced Bifurcation Systems hopes to be part of the solution. Mr. Laverty points out that heart disease is the number one killer of American women and cannot be considered a ‘male disease.’ While Dr. Khorsandi encourages people to remember the global scale of the problem.

Join us in supporting heart healthy organizations, programs and by encouraging behaviors that  will help us to reign in hart disease.


  • -

Charles Laverty Starts A Trip To China To Talk ABS

Category : News

CEO Charles Laverty is Blogging About his Trip to China

Heart disease in the number one global killer and Charley is there to talk with potential partners about opportunities to work together to tackle it. He already is sharing some humorous and insightful observations about travel to China.


  • -
Board of Directors welcomes Thomas O'Neill

Board of Directors New Member

Thomas O’Neill Joining ABS Board of Directors

ABS is very proud to announce the newest member of the Board of Directors, Thomas O’Neill.  Tom brings with him a wealth of knowledge and experience.

Tom founded Sandler O’Neill + Partners and was also lead for practice groups of notable companies such as Rothschild and Bear Stearns.

Advanced Bifurcation Systems CEO, Charles Laverty stated that ABS is thrilled to have Thomas join.  Also stating that they are thrilled to have his experience in medical devices and that this makes him particularly qualified.

The press release can be found here.

 


  • -
Scott King, VP of Regulatory Affairs

Welcoming Scott King

Category : Announcing , News

Scott King joins Advanced Bifurcation Systems 

Advanced Bifurcation Systems (ABS) announced that Scott King has joined the leadership team as Vice President of Regulatory Affairs and Chief Compliance Officer.

ABS is a clinical stage, medical device company whose stenting platform overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties.

Mr. King will direct ABS’s regulatory strategy and interface with the FDA as ABS seeks approval of its platform. “Scott brings to ABS over two decades of regulatory affairs and quality assurance experience, with a proven track record leading regulatory affairs for innovative medical device companies,” said Charles Laverty, CEO of Advanced Bifurcation Systems. “His industry expertise will be invaluable as we seek regulatory approval. We look forward to his contributions as a key member of our leadership team.”

Extensive Experience

Mr. King has extensive experience in setting global regulatory strategy, registration and pre-market notification, agency communications, and inspection and audit management. Prior to joining ABS, Mr. King was VP, Regulatory and Quality Affairs and Chief Compliance Officer at Ceterix Orthopaedics, which produces surgical tools for tissue joint injuries. There King developed the regulatory strategy and prepared the successful submission for the Company’s NovoStitch Plus Meniscal Repair System.

Mr. King also drafted and released procedure for evaluating post market product changes, and was responsible for evaluating changes and establishing regulatory strategies to support product research and development.

Before ABS

Prior to joining Ceterix Orthopaedics, Mr. King was Sr. Manager, Product Quality Assurance at Intuitive Surgical, which develops robotic-assisted technologies, tools and services that bring enhanced predictability to surgery.

King’s earlier roles include Associate Director, Regulatory Affairs and Quality Assurance at XDx Molecular Diagnostics (now CareDx), a molecular diagnostics company, and Manager, Quality Systems, at Kyphon (now Medtronic), a maker of spinal treatments.

Mr. King has a BS Biology from James Madison University in Virginia.


  • -
Inc verified profile for ABS

ABS profile verified on Inc

Category : Announcing , News

Inc profile Inc verified profile for ABS

Advanced Bifurcation Systems is now on  on Inc.  Inc is an invaluable resource for small business.

Inc magazine is a well known magazine for entrepreneurs and small business owners.  In addition, their site and magazine has extensive information that is useful for people who are just venturing out or are already established.

Advanced Bifurcation Systems profile on this site will prove to be a very valuable tool for our company.  Furthermore, it will provide us with opportunities that we did not know existed or were hesitant to go after.

 

 

 


  • -
Biospace profile for ABS

ABS now on Biospace

Biospace Profile

We are happy to announce that we are now profiled on Biospace.com.  This is a web space to go to for industry news and careers.

This site offers an extensive industry news and information on life sciences.  Biospace posts daily on breaking news in this field.  Which in turn keeps their followers and investors versed in the latest in the medical, pharmaceutical and biotech fields.

A Very Useful Site for the Industry

They also have career news and advice that is industry specific.  Career resources and support are also available.  You can sign up for newsletters.  Also their flagship GenePool of career and news updates that allows their feed to go directly to your inbox.

Advanced Bifurcations Systems has a career section and a profile on their site.  You can find out our latest offerings and find out more company information.

Please feel free to connect with us on any of our social media platforms.

 


  • -

ABS Awarded 34 International Patents With Many More In the Works

Category : Announcing , News

Advanced Bifurcation Systems announced today that is has been awarded 44 patents around the world and has 10 more in the works. ABS co-founder and chief medical officer Dr. Mehran Khorsand says this reflects his view that the ABS platform offers better tools to interventionist cardiologists than those available today. CEO Charles Laverty hailed the company’s progress saying that intellectual property is an important part of the company strategy.

See our News & Events Page For More Coverage


  • -

  • -

New Heart Stenting System Could Eliminate Heart Surgery for Many

Category : News

We are grateful for all the growing for the ABS platform and the coverage of the European Bifurcation Club meeting and human trials. This article is welcome coverage that explains how the Advanced Bifurcation System Platform could be a big benefit to interventionist cardiologists and patients alike. New Heart Stenting System Could Eliminate Heart Surgery for Many

See our News & Events Page For More Coverage


  • -